Trials / Completed
CompletedNCT02776514
Steroids, Hyaluronic Acid or Platelet Rich Plasma Versus Placebo for the Knee Osteoarthritis
Intraarticular Injections of Steroids, Hyaluronic Acid or Platelet Rich Plasma Versus Placebo for the Knee Osteoarthritis
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 120 (actual)
- Sponsor
- Balgrist University Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study investigates clinical outcome and imaging outcome parameters after intraarticular injection of steroids, platelet-rich-plasma (prp), hyaluronic acid or placebo in patients with early osteoarthritis of the knee joint.
Detailed description
Osteoarthritis of the knee joint is a very common disease in middle aged and elderly patients. This study evaluates the efficiency of different commonly used substances for intraarticular, non-operative treatment in early stages of this disease. 120 patients receive an fluoroscopic guided injection in the knee joint: 30 patients get injection with steroids 30 patients get injection with prp 30 patients get injection with hyaluronic acid 30 patients get injection with placebo (iopamiro contrast media) Primary outcome: - clinical outcome (pain using numeric rating scale) * Magnetic Resonance imaging (cartilage defects etc.)
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Triamcort | Fluoroscopic guided injection in the knee joint |
| DRUG | Platelet-rich-plasma | |
| DRUG | Suplasyn1 | |
| DRUG | Placebo |
Timeline
- Start date
- 2016-02-01
- Primary completion
- 2020-11-01
- Completion
- 2020-11-01
- First posted
- 2016-05-18
- Last updated
- 2022-02-07
Locations
1 site across 1 country: Switzerland
Source: ClinicalTrials.gov record NCT02776514. Inclusion in this directory is not an endorsement.